1. It's a real pity the UK drug regulator, MHRA, doesn't hold public advisory committee meetings to assess #Covid vaccines, in the way @US_FDA does. Would have been fascinating to listen to a detailed analysis of the AstraZeneca-Oxford vaccine's emergency use application.
Thread
3. Today the UK regulator approved the AZ-Ox vaccine for use in Britain. It's estimated to be about 70% effective, but the confidence intervals on that are wider than those for the Pfizer & Moderna vaccines. It works, but how well exactly is still a bit unclear.
4. The AZ-Ox vaccine wasn't approved for people under 18 yrs — no data.
There are also no real data on the vaccine's safety in pregnant or lactating people. But MHRA does not advise against vaccination of pregnant people; suggests it could be used when benefits outweigh risks.
5. MHRA recommends the AZ-Ox vaccine be given in 2 doses, between 4 & 12 weeks apart. That's an odd & probably unwieldy interval. There are hints this vaccine may work better with a longer interval between shots. How workable that is in the real world remains to be seen.
6. One of the terrific things about the AZ-Ox vaccine is it doesn't need ultracold chain. It should be stored at fridge temp before use, & can be kept at room temperature (not above 25 C) while a vial is in use. Huge advantage over the Pfizer & Moderna vaccines.
7. It should be noted the data used to authorize use of the AZ-Ox vax in the UK was drawn mainly from adults 64 and younger who were white. The lack of range and diversity in this trial is in marked contrast to the #Covid vaccine trials being run in the U.S.
8. Last point: Like the Pfizer & Moderna vaccines, this is reactogenic. Short term discomfort is common. Headache, muscle aches, nausea, fatigue, chills & injection site pain each reported by at least 1 in 10 people vaccinated. Vomiting & fever were reported by at least 1 in 100.
You can follow @HelenBranswell.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.